157
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10

, , , &
Pages 3222-3226 | Received 09 Jun 2022, Accepted 28 Aug 2022, Published online: 14 Sep 2022
 

Acknowledgements

The authors acknowledge all the patients that were included in the study. The authors are thankful to David Dittmann for his help with next-generation sequencing.

Author contributions

QC, and AB designed the study, collected and analyzed data, wrote the manuscript, and approved the final version. MS analyzed data and helped with the manuscript. YC and SM revised the manuscript and approved the final version.

Disclosure statement

AB has received honorarium for speaker bureau from Eli Lilly, Foundation Medicine/Roche China, Thermo Fisher scientific and Bayer. SM has Research Funding: Loxo; AstraZeneca; Juno; BeiGene; Abbvie; Janssen; TG Therapeutics; Pharmacyclics; Consultancy: AstraZeneca; Abbvie, BeiGene, Janssen, TG Therapeutics; Speakers Bureau: AstraZeneca; BeiGene; Janssen; Pharmacyclics.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.